Opioid-Induced Adrenal Insufficiency in a Patient Treated With Buprenorphine-Naloxone: A Case Report
Year: 2024
Type: article
Study design: Case Report
Abstract: With the rising clinical use of opioid agonist/antagonist medications for opioid use disorder (OUD), overlooked adverse events, such as adrenal insufficiency, are coming to the forefront. Opioid-induced adrenal insufficiency (OIAI) occurs when opioids dampen the hypothalamic-pituitary-adrenal (HPA) axis, leading to adrenal suppression. Opioid-induced adrenal insufficiency is associated with significant morbidity and can precipitate high-mortality adrenal crises. We present a case of a 33-year-old male patient, initially presenting with concern for gastrointestinal bleeding, in which Suboxone (buprenorphine/naloxone) was the likely culprit of a newly uncovered adrenal insufficiency.
Source: Cureus
DOI: 10.7759/cureus.72187
Authors: Mohamed M Ahmed, Matthew League, Ramsey Amoudi, Clayton M Smith
Institutions: University of Louisville Hospital, University of Louisville
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4403688035
